From being a passive backdrop, the tumour microenvironment (TME) is now recognised as a core 12 driver of cancer initiation, progression, metastasis, immune escape, and treatment response. As such, 13 there is a major shift from cancer-centric to TME-centric research, positioning TME as a hub for 14 therapeutic targets...
Nur Akmarina B. M. Said, Syed Mahmood, Kenneth K.W. To· Frontiers in Pharmacology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.